Management of Primary Plasma Cell Leukemia Remains Challenging Even in the Era of Novel Agents.
- Published in:
- Clinical Medicine Insights: Blood Disorders, 2021, v. 14, p. 1, doi. 10.1177/2634853521999389
- By:
- Publication type:
- Article
Works matching IS 1179545X AND DT 2021 AND VI 14
Results: 4
1
2
A Clinical Triad with Fatal Implications: Recrudescent Diffuse Large B-cell Non-Hodgkin Lymphoma Presenting in the Leukemic Phase with an Elevated Serum Lactic Acid Level and Dysregulation of the TP53 Tumor Suppressor Gene – A Case Report and Literature Review
- Published in:
- Clinical Medicine Insights: Blood Disorders, 2021, v. 14, p. 1, doi. 10.1177/2634853521994094
- By:
- Publication type:
- Article
3
Efficacy of Nuwiq ® (Simoctocog Alfa) in Patients with Hemophilia A Who Changed and Adhered to a Pharmacokinetic-Guided Prophylaxis Regimen in the NuPreviq Study.
- Published in:
- 2021
- By:
- Publication type:
- Letter
4
Occurrence of a Clonal T-Cell Population in a Case of Chronic Myelomonocytic Leukemia.
- Published in:
- Clinical Medicine Insights: Blood Disorders, 2021, v. 14, p. 1, doi. 10.1177/2634853521991509
- By:
- Publication type:
- Article